Functional Imaging of HER2-Positive Metastatic Breast Cancer Using (64)Cu-DOTA-Trastuzumab Positron Emission Tomography

Por Mortimer, Joanne E., Bading, James R., Colcher, David M., Conti, Peter S., Frankel, Paul H., Carroll, Mary I., Tong, Shan, Poku, Erasmus, Miles, Joshua K., Shively, John E., Raubitschek, Andrew A.
Publicado em 2013

A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fuoro-2′-deoxycytidine, administered with tetrahydrouridine

Por Newman, Edward M., Morgan, Robert J., Kummar, Shivaani, Beumer, Jan H., Blanchard, M. Suzette, Ruel, Christopher, El-Khoueiry, Anthony B., Carroll, Mary I., Hou, Jessie M., Li, Chun, Lenz, Heinz J., Eiseman, Julie L., Doroshow, James H.
Publicado no Cancer Chemother Pharmacol (2015)